This inventor holds 5 USPTO granted patents. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2001-2008.
Company Filing History:
Years Active: 2001-2008
Title: Jacek Bigda: Innovator in Immunology
Introduction
Jacek Bigda is a prominent inventor based in Gdansk, Poland. He has made significant contributions to the field of immunology, particularly in the development of diagnostic assays and therapeutic antibodies. With a total of 5 patents, his work has advanced the understanding and treatment of various diseases.
Latest Patents
Among his latest patents, Jacek Bigda has developed methods for determining the level of human TBP-II using anti-TBP-II antibodies. This innovation includes antibodies to tumor necrosis factor receptors (TNF-Rs) and outlines methods for producing these antibodies, as well as their applications in immunoassays and the purification of TBP-II through affinity chromatography. Additionally, he has patented a diagnostic assay for endogenous antibodies to TBP-II. Another notable patent involves a DNA molecule encoding TNF binding ligands, which includes DNA that encodes antibodies to TNF-Rs. These antibodies are designed to inhibit the cytotoxic effects of TNF without interfering with its binding to TNF-Rs.
Career Highlights
Jacek Bigda is currently associated with Yeda Research and Development Co. Ltd. His work has been instrumental in bridging the gap between research and practical applications in immunology. His innovative approaches have garnered attention in the scientific community.
Collaborations
Some of his notable coworkers include David Wallach and Igor Beletsky, who have collaborated with him on various research projects. Their combined expertise has contributed to the advancement of immunological research.
Conclusion
Jacek Bigda's contributions to immunology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of diagnostic and therapeutic solutions.